Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04936503Completed
Open-label trial, sponsored by Centre Hospitalier Universitaire de Bordeaux. Primary endpoints: Presence of rhythmic risk markers by the questionnaire at 0 days, Evaluation by resting ECG of rhythmic risk marker: repolarization disorders at 0 days and 2 more. Started Jun 2020; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04936503.